Infection often complicates systemic lupus erythematosus (SLE) and has
become the most common cause of death in patients with SLE. It is, th
erefore, important to identify risk factors for infection in the manag
ement of SLE patients. Risk factor modification or prophylactic antibi
otic use could decrease the incidence or severity of infection, improv
ing the prognosis for SLE patients. The following risk factors for inf
ection have been reported: an increase in disease activity of SLE, pre
sence of nephrotic syndrome or renal failure attributed to lupus nephr
itis, an increase in corticosteroid dose, use of cytotoxic drugs, espe
cially cyclophosphamide, and a decrease in serum albumin value. A pred
iction model for infection using these risk factors appears applicable
in clinical practice, and two such models have been reported: one pre
dicting infection from disease activity of SLE, and the other a logist
ic model using serum albumin value, serum creatinine value and cortico
steroid dose as independent variables.